Our drug Ranitidine is safe: Strides Pharma
Ranitidine is a commonly prescribed medicine for countering acidity and is on the WHO ’s Model List of Essential Medicines. In India, a host of companies including GalxoSmithKline, JB Chemicals, Cadila Pharma, Zydus Cadila, Dr Reddy’s and Sun Pharmaceuticals sell over 180 versions of the drug. Strides Pharma is likely to resume drug sale, following the report. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 3, 2019 Category: Pharmaceuticals Source Type: news
Lannett Issues Voluntary Nationwide Recall of Ranitidine Syrup (Ranitidine Oral Solution, USP), 15mg/ml due to an Elevated Level of the Unexpected Impurity, N-Nitrosodimethylamine (NDMA)
Lannett Company, Inc. today announced that it is voluntarily recalling all lots within expiry of Ranitidine Syrup (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - October 29, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Novitium Pharma Issues Voluntary National Recall of Ranitidine Hydrochloride Capsules 150mg and 300mg Due to an Elevated Amount of Unexpected Impurity, N-Nitrosodimethylamine (NDMA)
Voluntarily recalling all quantities and lots, within expiry, of Ranitidine Hydrochloride Capsules in the US to the consumer level. Ranitidine Hydrochloride Capsules are being recalled because of potential N-Nitrosodimethylamine (NDMA) amounts above levels established by the FDA. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - October 25, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Boots and Morrisons' own version of Zantac are recalled
Perrigo Company supplies ranitidine - the generic form of the branded heartburn drug - to both of the British retail giants. It announced the recall in an alert sent out by UK health chiefs today. (Source: the Mail online | Health)
Source: the Mail online | Health - October 25, 2019 Category: Consumer Health News Source Type: news
Class 2 Medicines recall: Ranitidine 150mg/10ml Oral Solution
Rosemont Pharmaceuticals Limited is recalling unexpired stock from pharmacies as a precautionary measure due to possible contamination with an impurity.
Further information, details of the affected (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - October 25, 2019 Category: Drugs & Pharmacology Source Type: news
Dr Reddy ’s recalled all batches of heartburn drug from US
Ranitidine is commonly prescribed as an antacid and the NDMA impurity scandal had rocked Indian generic makers present in US who were one of the largest suppliers of the drug. After FDA ’s cautionary note, several Indian cos had to recall this product. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 24, 2019 Category: Pharmaceuticals Source Type: news
Dr. Reddy's is recalling some products used to treat heartburn
Dr. Reddy's Laboratories Ltd. and its subsidiaries issued a voluntary nationwide recall of its ranitidine medicines used to treat heartburn, the US Food and Drug Administration said on Wednesday. (Source: CNN.com - Health)
Source: CNN.com - Health - October 24, 2019 Category: Consumer Health News Source Type: news
U.S. FDA says carcinogen not found in alternatives of Zantac and its generics
U.S. retailers Walmart Inc, CVS Health Corp Walgreens Boots Alliance Inc and Rite Aid Corp have all removed Zantac off their shelves after some drugs containing its key ingredient ranitidine were found to have traces of the impurity, N-nitrosodimethylamine (NDMA). (Source: Reuters: Health)
Source: Reuters: Health - October 24, 2019 Category: Consumer Health News Tags: healthNews Source Type: news
Perrigo Company plc Issues Voluntary Worldwide Recall of Ranitidine Due to Possible Presence of Impurity, N-nitrosodimethylamine (NDMA) Impurity in the Product
As a precautionary measure, Perrigo Company plc announced today that it has initiated a voluntary, worldwide product recall to the retail customer level of ranitidine (all pack sizes). The recall is being taken due to possible presence of a nitrosamine impurity called N-nitrosodimethylamine (NDMA). (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - October 23, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Dr. Reddy ’s Confirms its Voluntary Nationwide Recall of All Ranitidine Products in the U.S. Market
Nationwide recall on October 1, 2019, (at the retail level for over-the-counter products and at the consumer level for prescription products) of all of its ranitidine medications sold in US due to confirmed contamination with N-Nitrosodimethylamine (NDMA) above levels established by the FDA (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - October 23, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news
